Relx (NYSE:RELX – Get Free Report) and Pazoo (OTCMKTS:PZOO – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.
Profitability
This table compares Relx and Pazoo’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Relx | N/A | N/A | N/A |
| Pazoo | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent ratings and price targets for Relx and Pazoo, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Relx | 0 | 1 | 4 | 1 | 3.00 |
| Pazoo | 0 | 0 | 0 | 0 | 0.00 |
Insider & Institutional Ownership
15.0% of Relx shares are owned by institutional investors. 0.0% of Relx shares are owned by company insiders. Comparatively, 6.2% of Pazoo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Volatility and Risk
Relx has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Pazoo has a beta of -0.79, indicating that its stock price is 179% less volatile than the S&P 500.
Earnings and Valuation
This table compares Relx and Pazoo”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Relx | $12.06 billion | 6.13 | $2.47 billion | N/A | N/A |
| Pazoo | N/A | N/A | N/A | N/A | N/A |
Relx has higher revenue and earnings than Pazoo.
Summary
Relx beats Pazoo on 6 of the 8 factors compared between the two stocks.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk & Business Analytics segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The company was founded by Albert Edward Reed in 1903 and is headquartered in London, the United Kingdom.
About Pazoo
Pazoo, Inc. operates as a health and wellness company. It offers laboratory testing services for marijuana. Pazoo, Inc.was formerly known as IUCSS, Inc. and changed its name to Pazoo, Inc. in May 2011. The company was founded in 2010 and is headquartered in East Hanover, New Jersey.
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
